✦ LIBER ✦

Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening

✍ Scribed by D. D. Koeberl; D. S. Millington; W. E. Smith; S. D. Weavil; J. Muenzer; S. E. McCandless; P. S. Kishnani; M. T. McDonald; S. Chaing; A. Boney; E. Moore; D. M. Frazier

Book ID: 111538397
Publisher: Springer
Year: 2003
Tongue: English
Weight: 94 KB
Volume: 26
Category: Article
ISSN: 0141-8955
DOI: 10.1023/a:1024015227863

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3-Methylcrotonyl-CoA carboxylase deficie

3-Methylcrotonyl-CoA carboxylase deficiency: Mutation analysis in 28 probands, 9 symptomatic and 19 detected by newborn screening

✍ Maria Fernanda Dantas; Terttu Suormala; Ann Randolph; David Coelho; Brian Fowler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Isolated 3-methylcrotonyl-CoA carboxylase (MCC) deficiency is an autosomal recessive disorder that appears to be the most frequent organic aciduria detected in tandem mass spectrometry (TMS)-based neonatal screening programs. The phenotype is variable, ranging from neonatal onset with severe neurolo

Pseudo-glutarylcarnitinaemia in medium-c

Pseudo-glutarylcarnitinaemia in medium-chain acyl-CoA dehydrogenase deficiency detected by tandem mass spectrometry newborn screening

✍ N. Napolitano; V. Wiley; J. J. Pitt 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 196 KB

Neonatal diagnosis of long-chain 3-hydro

Neonatal diagnosis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and implications for newborn screening by tandem mass spectrometry

✍ K. H. Carpenter; B. Wilcken 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 32 KB

An asymptomatic infant with isolated 3-m

An asymptomatic infant with isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency detected by newborn screening for maple syrup urine disease

✍ K. Ihara; R. Kuromaru; Y. Inoue; T. Kuhara; I. Matsumoto; M. Yoshino; J. Fukushi 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 114 KB

Newborn screening for 3-methylcrotonyl-C

Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment

✍ Sonja C. Stadler; Roman Polanetz; Esther M. Maier; Sylvia C. Heidenreich; Birgit 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Communicated by Ronald Wanders New technology enables expansion of newborn screening (NBS) of inborn errors aimed to prevent adverse outcome. In conditions with a large share of asymptomatic phenotypes, the potential harm created by NBS must carefully be weighed against benefit. Policies vary t

Analysis of cases of 3-methylcrotonyl Co

Analysis of cases of 3-methylcrotonyl CoA carboxylase deficiency (3-MCCD) in the California newborn screening program reported in the state database

✍ Lam, Christina; Carter, Jennifer M.; Cederbaum, Stephen D.; Neidich, Julie; Gall 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 205 KB